Advocacy Actions
European Chamber Representatives meet with German Ambassador to the EU
On 12th January a group of European Chamber representatives led by President Joerg Wuttke met with German Ambassador to the EU Michael Clauss.
Read moreMeeting with EUD representatives from DG TRADE and GROW on public procurement
On 12th January European Chamber Business Managers from various Working Groups met with DG TRADE and DG GROW representatives at the EU Delegation to discuss procurement related questions.
Read moreMeeting with Centre of International Cooperation of the Ministry of Emergency Management (MEM)
On 7th January, Ms Hu Yuhong, Deputy Head of the Centre of International Cooperation and representatives of Ministry of Emergency Management (MEM) visited the European Chamber Beijing office to discuss future cooperation opportunities.
Read moreMeeting with Changning Deputy District Mayor Weng Huajian
On Tuesday, 5th January, General Manager of the European Chamber Shanghai Chapter Dr Ioana Kraft met with the Changning Deputy District Mayor Mr Weng Huajian and his colleagues to discuss future cooperation and implementation of the 14th Five Year Plan.
Chief Negotiator for CAI debriefs European Chamber representatives on the Agreement
On 5th January, Chief Negotiator for the Comprehensive Agreement on Investment (CAI) Ms Maria Martin Prat and her team debriefed a group of Chamber industry representatives on the key points of the Agreement.
Read moreComments to the MoF's draft 'Amendment of the Government Procurement Law'
The Public Procurement Taskforce submitted comments to the Ministry of Finance's (MoF's) draft 'Amendment of the Government Procurement Law'.
Read moreComments to the CDR’s “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”
On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Formatting of the Regular Risk Assessment Report by the Medical Devices (MAH)”.
Read moreMeeting with the Center for Drug Re-evaluation for implementing Order#1 of SAMR
The Healthcare Equipment (HCE) Working Group and European Coordination Committee of the Radiological, Electromedical And Healthcare IT Industry (COCIR) visited the Center for Drugs (Medical Devices) Re-evaluation (CDR) of National Medical Products Administration (NMPA) on 29th December 2018.
Read moreComments to the CDR’s “Guideline for the Re-evaluation of Medical Devices”
On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Re-evaluation of Medical Devices”.
Read moreComments to the CDR’s “Guideline for the Risk Assessment by the Medical Device Market Authorisation Holder (MAH)”
On 27 November 2018, the Centre for Drug Re-evaluation has initiated a public consultation on “Guideline for the Risk Assessment by the Medical Device Market Authorisation Holder (MAH)”.
Read more